Therabron Therapeutics therabron.com


Public list: Pharma Startups (4740) Rare Diseases (230)

Therabron Therapeutics, forrmerly Clarassance, is a clinical-stage biotechnology company that develops protein drugs to treat respiratory diseases. The company's products aim to restore the natural immune balance in the lungs of respiratory patients through the administration of synthetic human CC10 proteins. The family of CC10 proteins, also known as secretoglobins, have the potential to change the course of acute and chronic respiratory diseases, representing large markets into which few truly...Show all

Therabron Therapeutics, forrmerly Clarassance, is a clinical-stage biotechnology company that develops protein drugs to treat respiratory diseases. The company's products aim to restore the natural immune balance in the lungs of respiratory patients ...Show all

Company (Alive / Active)

Phone: 240-205-7271

Fax:

9430 Key West Avenue
#125
Rockville, 20850
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Therabron Therapeutics $21.6M Dec 27, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Therabron Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
New Markets Venture PartnersVenture CapitalFulton, Maryland, United StatesSeries B - II, Series B
Undisclosed InvestorsOtherDebt, Series A - II, Series A
U.S. ArmyGovernmentUnited StatesGrant
Brace Pharma CapitalCorporate VentureRockville, Maryland, United StatesSeries B - II, Series B
Zell Biotech FundsVenture CapitalWashington, DC, United StatesSeries B - II, Series B
See all 5 investors
There is no Competitors data available for this company. Please select another tab.